Announcements Trials
Browse Landscape

Status

Completed 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1Breast 1

Conditions

Melanoma 1Lung Neoplasms 1Chronic Disease 1COVID-19 1Breast Neoplasms 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × OTHER × COVID-19 Vaccines × Clear all
NCT04821570 2023-04-04

CANINE

University of Kansas Medical Center

Unknown
500 enrolled
BreastDermatologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma

NCT05043246 2022-08-10

SIM-PBD

The Second Affiliated Hospital of Chongqing Medical University

Unknown
2,300 enrolled

COVID-19, Chronic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡